Abstract:Objective To explore the feasibility of 131I radiotherapy mediated by hNIS gene transfection in nasopharyngeal carcinoma (NPC).Methods NPC xenograft models were established with CNE-2-hNIS cells (experimental group) and CNE-2 cells (control group).Radioactivity of different organs of nude mice was counted at 0.5,1,2,6 and 24 h after intraperitoneal injection of 125I using a gamma counter.99TcmO4-imaging was also performed in nude mice.Changes in the xenograft tumor volume were observed after 131I treatment in the experimental group and control group.Cell apoptosis was detected after 131I treatment by the terminal oxynucleotidyl transferase mediated dUTP biotin nick end labeling (TUNEL) method and caspase 3 and Ki67 expressions measured with immunohistochemistry of the tumor tissue.Statistical analysis was performed using SPSS 13.0 software,and the mean values between groups were compared using t test.Results CNE-2-hNIS and CNE-2 NPC xenografts were established successfully in nude mice.Biodistribution of 125I in tumor-bearing nude mice showed enhanced tumor uptake of 125I in the experimental group,with peak uptake at 1 h ((20.28 ± 0.15)％).The biological half-life of 125I in the tumors transfected with hNIS was about 1.56 h.Imaging studies showed that the tumors in the experimental group accumulated 99TcmO-4 with a peak at 1.5-2 h,whereas the control tumors were not visualized.The mean volume of the experimental xenograft tumors was (0.44 ±0.04) cm3 before 131I treatment and increased to (0.97 ±0.08) cm3 after 131I treatment.However,the volume of the control xenografts was (0.45 ± 0.06) cm3 before 131I treatment and (2.98 ±0.16) cm3 after 131I treatment.The tumor volume of the experimental group was significantly smaller compared with that of the control group after 131I treatment (t =19.46,P ＜ 0.01).A higher apoptotic index and caspase 3 positive rate as well as lower Ki67 proliferation index were observed in the experimental group after 131I treatment ((0.66 ± 0.07) ％,(0.56 ± 0.14) ％,(0.22 ± 0.10) ％,respectively) compared with those before 131I treatment ((0.08 ± 0.06)％,(0.13 ± 0.04)％ and (0.65 ±0.11)％,t =10.89,5.12,5.01,respectively,all P ＜0.05).Conclusions The transfected hNIS gene may mediate uptake of 125I,131I and 99TcmO-4 in NPC xenografts and thus provides potential for radionuclide imaging and radiotherapy for NPC.131I may effectively inhibit proliferation and induce apoptosis of NPC xenografts transfected with the hNIS gene.

Radionuclide Imaging and Therapy Mediated by Hnis Gene Transfection in Nasopharyngeal Carcinoma Xenograft Model

Experimental Study of Nasopharyngeal Carcinoma Radionuclide Imaging and Therapy Using Transferred Human Sodium/Iodide Symporter Gene

In vivo molecular imaging and radionuclide (131I) therapy of human nasopharyngeal carcinoma cells transfected with a lentivirus expressing sodium iodide symporter

The experimental study of radionuclide imaging and treatment of cervical cancer mediated by hNIS gene transfection

Evaluation of Therapy Effect of "1"3"1I Treatment of Nasopharyngeal Carcinoma Xenograft Mediated by Hnis Gene Transfection in Vivo Using Diffusion Weighted MR

Evaluation of therapy effect of 131Ⅰ treatment of nasopharyngeal carcinoma xenograft mediated by hNIS gene transfection in vivo using diffusion weighted MR

Evaluation of therapy effect of 131I treatment of nasopharyngeal carcinoma xenograft mediated by hNIS gene transfection in vivo using diffusion weighted MR

In Vivo Molecular Imaging And Radionuclide (I-131) Therapy Of Human Nasopharyngeal Carcinoma Cells Transfected With A Lentivirus Expressing Sodium Iodide Symporter

Study On Molecular Imaging And Radionuclide Therapy Of Human Nasopharyngeal Carcinoma Cells Transfected With Baculovirus-Mediated Sodium/Iodine Symporter Gene

Radionuclide imaging of large cell lung cancer in nude mice mode by transfected human sodium/iodide symporter gene

Study on Hnis Mediated Transferring Gene ^99Mtco4^- Imaging and ^131I Treatment in Xenografted Ovarian Cancer

Effect of 131I on Proliferation and Apoptosis of Nasopharygeal Carcinoma Cell Transferred Human Sodium/iodide Symporter Gene

The Preclinical Study Of Predicting Radiosensitivity In Human Nasopharyngeal Carcinoma Xenografts By F-18-Ml-10 Animal-Pet/Ct Imaging

Radioactive ¹²⁵I seed inhibits the cell growth, migration, and invasion of nasopharyngeal carcinoma by triggering DNA damage and inactivating VEGF-A/ERK signaling.

Theranostic Studies of Human Sodium Iodide Symporter Imaging and Therapy Using 188re: a Human Glioma Study in Mice.

Sodium/iodide symporter gene transfection increases radionuclide uptake in human cisplatin-resistant lung cancer cells

NES1/KLK10 and Hnis Gene Therapy Enhanced Iodine-131 Internal Radiation in PC3 Proliferation Inhibition

The Study of Irradiation in Combination with Endostar Therapy for Human Nasopharyngeal Carcinoma Xenografts in Nuke Mice

The preclinical study of predicting radiosensitivity in human nasopharyngeal carcinoma xenografts by 18F-ML-10 animal- PET/CT imaging.

Survivin Special Sirna Enhanced Radiosensitivity of Nasopharyngeal Carcinoma Cells Transferred Human Sodium/iodide Symporter Gene to 131 I

Human Sodium Iodide Transporter Gene-Mediated Imaging and Therapy of Mouse Glioma, Comparison Between 188re and 131I.